{"chebi_id":"65349","chebi_name":"mirabegron","chebi_synonyms":["2-(2-amino-1,3-thiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl]acetamide","Myrbetriq"],"diffprof_id_observed":["MTBLS2871_0002_00000009"],"diffprof_id_var_observed":[],"inchikey":"PBAPPPCECJKMCM-IBGZPJMESA-N","inn_name":"mirabegron","iupac_name":"2-(2-amino-1,3-thiazol-4-yl)-<em>N</em>-[4-(2-{[(2<i>R</i>)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl]acetamide","num_study_observed":1,"reactome_ids":["R-HSA-162582","R-HSA-372790","R-HSA-373076","R-HSA-375280","R-HSA-390696","R-HSA-500792"],"reactome_names":["Signal Transduction","Signaling by GPCR","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Adrenoceptors","GPCR ligand binding"],"study_id_observed":["MTBLS2871"],"study_id_var_observed":[],"synonym_name":""}